Martin Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$2.5M Sell
16,296
-750
-4% -$120K 6.85% 7
2015
Q1
$2.73M Hold
17,046
7.72% 5
2014
Q4
$2.71M Sell
17,046
-1,861
-10% -$290K 7.01% 7
2014
Q3
$2.66M Sell
18,907
-1,155
-6% -$151K 8.71% 6
2014
Q2
$2.38M Sell
20,062
-400
-2% -$46.3K 7.14% 6
2014
Q1
$2.52M Sell
20,462
-1,135
-5% -$138K 7.18% 6
2013
Q4
$2.46M Sell
21,597
-2,396
-10% -$273K 6.58% 8
2013
Q3
$2.69M Sell
23,993
-27,390
-53% -$2.97M 6.45% 6
2013
Q2
$5.07M Buy
+51,383
New +$5.33M 11.3% 3

Other funds holding AMGN

Martin Capital Management's AMGN Position: Q2 2015 in Review

Martin Capital Management reduced its Amgen (AMGN) stake by 4.4% in Q2 2015, selling an estimated $120K and leaving 16,296 shares worth $2.5M. The position accounts for 6.85% of the portfolio, ranked #7.

Martin Capital Management first reported a position in AMGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $5.07M in Q2 2013. 1,367 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

  • Martin Capital Management held 16,296 shares of Amgen worth $2.5M as of Q2 2015.
  • Martin Capital Management sold 750 Amgen shares in Q2 2015, an estimated $120K.
  • Amgen made up 6.85% of Martin Capital Management's portfolio in Q2 2015, its #7 holding.
  • Martin Capital Management first reported a position in Amgen in Q2 2013 and has held it in 9 quarters since.
  • Martin Capital Management's Amgen position peaked at $5.07M in Q2 2013.
  • 1,367 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Martin Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.